Free Trial
→ Trump’s New Dollar revealed (From Porter & Company) (Ad)tc pixel Free MOTS Stock Alerts

Motus GI (MOTS) Competitors

Motus GI logo
Compare

MOTS vs. UTRS, DRTSW, ANZUW, CNXU, and HSCSW

Should you buy Motus GI stock or one of its competitors? MarketBeat compares Motus GI with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Motus GI include Minerva Surgical (UTRS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Conexeu Sciences (CNXU), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry.

How does Motus GI compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

Motus GI has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Motus GI$319K0.00-$12.87M-$14.69N/A

20.1% of Motus GI shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by insiders. Comparatively, 0.3% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Minerva Surgical has a beta of 2.92, meaning that its stock price is 192% more volatile than the broader market. Comparatively, Motus GI has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Motus GI Neutral

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Motus GI N/A N/A N/A

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Motus GI compare to Alpha Tau Medical?

Motus GI (NASDAQ:MOTS) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

Alpha Tau Medical has lower revenue, but higher earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

20.1% of Motus GI shares are owned by institutional investors. 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Alpha Tau Medical had 1 more articles in the media than Motus GI. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for Motus GI. Alpha Tau Medical's average media sentiment score of 1.89 beat Motus GI's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Motus GI Neutral
Alpha Tau Medical Very Positive

Summary

Motus GI beats Alpha Tau Medical on 3 of the 5 factors compared between the two stocks.

How does Motus GI compare to Anzu Special Acquisition Corp I?

Motus GI (NASDAQ:MOTS) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

20.1% of Motus GI shares are owned by institutional investors. 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Anzu Special Acquisition Corp I'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Anzu Special Acquisition Corp I Neutral

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

Summary

Motus GI beats Anzu Special Acquisition Corp I on 3 of the 3 factors compared between the two stocks.

How does Motus GI compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Motus GI (NASDAQ:MOTS) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

Conexeu Sciences has higher earnings, but lower revenue than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conexeu SciencesN/AN/AN/AN/AN/A
Motus GI$319K0.00-$12.87M-$14.69N/A

In the previous week, Conexeu Sciences had 6 more articles in the media than Motus GI. MarketBeat recorded 6 mentions for Conexeu Sciences and 0 mentions for Motus GI. Conexeu Sciences' average media sentiment score of 0.51 beat Motus GI's score of 0.00 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Conexeu Sciences Positive
Motus GI Neutral

Company Net Margins Return on Equity Return on Assets
Conexeu SciencesN/A N/A N/A
Motus GI N/A N/A N/A

20.1% of Motus GI shares are owned by institutional investors. 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Motus GI beats Conexeu Sciences on 3 of the 5 factors compared between the two stocks.

How does Motus GI compare to Heart Test Laboratories?

Heart Test Laboratories (NASDAQ:HSCSW) and Motus GI (NASDAQ:MOTS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

Heart Test Laboratories has higher earnings, but lower revenue than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart Test Laboratories$8.67KN/AN/AN/AN/A
Motus GI$319K0.00-$12.87M-$14.69N/A

Company Net Margins Return on Equity Return on Assets
Heart Test LaboratoriesN/A N/A N/A
Motus GI N/A N/A N/A

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Heart Test Laboratories had 1 more articles in the media than Motus GI. MarketBeat recorded 1 mentions for Heart Test Laboratories and 0 mentions for Motus GI. Heart Test Laboratories' average media sentiment score of 1.89 beat Motus GI's score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the media.

Company Overall Sentiment
Heart Test Laboratories Very Positive
Motus GI Neutral

Summary

Motus GI beats Heart Test Laboratories on 3 of the 5 factors compared between the two stocks.

Get Motus GI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOTS vs. The Competition

Export
MetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$39.24M$6.64B$12.06B
Dividend YieldN/A1.08%2.67%5.55%
P/E Ratio0.0014.3924.5023.76
Price / SalesN/A26.16503.68105.22
Price / CashN/A18.8742.3656.09
Price / BookN/A14.3310.366.72
Net Income-$12.87M-$20.60M$3.56B$337.35M

Motus GI Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
DRTSW
Alpha Tau Medical
N/A$2.54
-0.8%		N/A+620.0%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.06
flat		N/A-9.1%$0.00N/AN/A2
CNXU
Conexeu Sciences
N/A$13.63
-1.0%		N/AN/A$0.00N/AN/A4

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MOTS) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners
He Called NVIDIA at $1.10 – Now He Says, “SELL”
The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...
The Oxford Club | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Stranded On The Flood Plains of History
The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...
Porter & Company | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Tesla. SolarCity. Twitter. This $4 stock is next.
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel